S&T Bank Novo Nordisk A S Transaction History

S&T Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $24,542 - $29,382	-200 Reduced 12.27%	1,430 $204,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $166,439 - $221,549	1,630 New	1,630 $209,000
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $30,765 - $40,599	-300 Reduced 8.37%	3,285 $445,000
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $223,908 - $274,785	-2,350 Reduced 39.6%	3,585 $357,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $1,772 - $2,239	-21 Reduced 0.35%	5,935 $570,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $135 - $169	-2 Reduced 0.03%	5,956 $499,000
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $536 - $606	8 Added 0.13%	5,958 $402,000
Q4 2020 Feb 17, 2021	BUY	$63.89 - $73.8 $380,145 - $439,110	5,950 New	5,950 $416,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $198B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

Stay updated on S&T Bank with notifications on news.